JP Morgan analyst updates estimates for Agilon Health, Inc. based on Q4 results and management’s outlook for recovery and growth in 2025-2027.
Latest Ratings for AGL
DateFirmActionFromTo Dec 2021Deutsche BankMaintainsBuy Nov 2021SVB LeerinkMaintainsOutperform Oct 2021JefferiesInitiates Coverage OnBuy